Helix Fund PCC

Structura et Incrementum

A protected cell company engineered so structure and growth reinforce one another — capital ring-fenced by design, compounding through discipline.

About Helix

Built to compartmentalize risk, not returns.

Helix Fund PCC exists on a simple premise: growth compounds more reliably when it is protected from risks it did not take. Each strategy we run is housed in its own segregated cell — legally and operationally distinct — so that performance, exposure, and capital stay attributable to the decision that produced them.

The structure is deliberate rather than defensive. It lets us admit new strategies, investor classes, or mandates without diluting the governance or track record of any existing cell — much like a strand added to a helix extends the structure without unwinding it.

2025
Established
Mauritius
Domicile
Financial Services Commission (FSC)
regulatory regime
Structure

Segregation by design.

01

Ring-fenced cells

Each strategy operates inside its own segregated cell. The assets and liabilities of one cell are legally protected from the creditors or losses of any other.

02

Single governance core

One board, one custodian, one administrator oversee every cell — giving investors institutional-grade oversight without cross-cell exposure.

03

Independent NAV

Each cell strikes and reports its own net asset value, so performance and risk are always traceable to the strategy that generated them.

04

Regulatory segregation

Structured under [Jurisdiction] protected cell company legislation, with every cell registered and reported as its own segregated portfolio.

Approach

Structura et Incrementum, in practice.

Structure

Engineer the container first

Before a strategy is deployed, its cell is defined — capital, mandate, and risk limits fixed in advance so growth never outpaces its guardrails.

Discipline

Consistency over conviction

A repeatable process, applied the same way in calm and stressed markets, matters more to us than any single high-conviction call.

Incrementum

Compounding, not spiking

We underwrite each cell for a long horizon, favouring durable compounding over returns that don't survive a full cycle.

Contact

Start a conversation.

For allocator, advisor, or cell-specific enquiries, reach the team directly — we're happy to walk through the structure in detail.

Email the Team